A new AI system uses routine mammograms to identify women at high risk for cardiovascular disease by measuring breast arterial calcifications.
Key Details
- 1The AI tool is a transformer-based neural network that quantifies CVD risk based on breast arterial calcifications (BACs) seen in screening mammograms.
- 2Study included retrospective analysis of nearly 124,000 women from two healthcare systems.
- 3BACs were categorized as zero, mild, moderate, or severe, and these categories were correlated with future major adverse cardiovascular events.
- 4Routine mammography provides an accessible, cost-effective opportunity for early CVD risk detection in women.
- 5Research was led by Dr. Hari Trivedi at Emory University, Department of Radiology.
Why It Matters
This approach leverages widely performed breast screening to address underdiagnosis of heart disease in women, allowing early intervention for cardiovascular risk using imaging AI. If validated, it could integrate seamlessly into current screening practices and improve population health.
Source
Radiology Business
Related News
•AuntMinnie
Deep Learning Model Predicts Brain Tumor MRI Enhancement Without Gadolinium
German researchers developed a deep learning approach to predict MRI contrast enhancement in brain tumors without the need for gadolinium-based agents.
•Radiology Business
Study Highlights Limitations of AI in Prostate MRI Screening
New research points to several shortcomings in implementing AI for MRI-based prostate cancer screening.
•HealthExec
Stanford Study: LLM-Generated Hospital Notes Safe, Aid Physician Wellbeing
Stanford research shows agentic LLMs can safely draft hospital discharge summaries, reducing physician burnout with minimal risk of patient harm.